Exact Mass: 339.1237

Exact Mass Matches: 339.1237

Found 97 metabolites which its exact mass value is equals to given mass value 339.1237, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Tetraphenylphosphonium

Tetraphenylphosphonium

C24H20P+ (339.1303)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents D000970 - Antineoplastic Agents

   

Phenoxybenzamine HCl

Phenoxybenzamine hydrochloride

C18H23Cl2NO (339.1157)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Phenoxybenzamine hydrochloride is a nonselective, irreversible, orally active α-adrenoceptor antagonist that is commonly used for the research of hypertension, specifically caused by pheochromocytoma. Phenoxybenzamine hydrochloride also shows antitumor activity[1][2].

   

Moguisteine

Moguisteine

C16H21NO5S (339.114)


C78273 - Agent Affecting Respiratory System > C74536 - Mucolytic Agent

   

5-Hydroxytryptophol glucuronide

(2R,3R,4S,5S,6R)-2-{[3-(2-hydroxyethyl)-1H-indol-5-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C16H21NO7 (339.1318)


5-Hydroxytryptophol glucuronide (GTOL) is the major excretion form of 5-hydroxytryptophol (5-HTOL), a minor serotonin metabolite under normal conditions. Because the concentration of 5-HTOL is markedly increased following consumption of alcohol, measurement of 5-HTOL is used as a sensitive biomarker for detection of recent alcohol intake. PMID: 15664340. 5-Hydroxytryptophol glucuronide provided higher diagnostic specificity and sensitivity than 5-hydroxytryptophol. PMID: 17112495. 5-Hydroxytryptophol glucuronide (GTOL) is the major excretion form of 5-hydroxytryptophol (5-HTOL), a minor serotonin metabolite under normal conditions. Because the concentration of 5-HTOL is markedly increased following consumption of alcohol, measurement of 5-HTOL is used as a sensitive biomarker for detection of recent alcohol intake. PMID: 15664340

   

7-Hydroxygliclazide

N-{5-hydroxy-octahydrocyclopenta[c]pyrrol-2-yl}-N-(4-methylbenzenesulphonyl)carbamimidic acid

C15H21N3O4S (339.1253)


7-Hydroxygliclazide is only found in individuals that have used or taken Gliclazide. 7-Hydroxygliclazide is a metabolite of Gliclazide. 7-hydroxygliclazide belongs to the family of Benzenesulfonamides. These are organic compounds containing a sulfonamide group that is S-linked to a benzene ring.

   

6-Hydroxygliclazide

N-{4-hydroxy-octahydrocyclopenta[c]pyrrol-2-yl}-N-(4-methylbenzenesulphonyl)carbamimidic acid

C15H21N3O4S (339.1253)


6-Hydroxygliclazide is only found in individuals that have used or taken Gliclazide. 6-Hydroxygliclazide is a metabolite of Gliclazide. 6-hydroxygliclazide belongs to the family of Benzenesulfonamides. These are organic compounds containing a sulfonamide group that is S-linked to a benzene ring.

   

Methylhydroxygliclazide

N-[4-(Hydroxymethyl)benzenesulphonyl]-n-{octahydrocyclopenta[c]pyrrol-2-yl}carbamimidic acid

C15H21N3O4S (339.1253)


Methylhydroxygliclazide is only found in individuals that have used or taken Gliclazide. Methylhydroxygliclazide is a metabolite of Gliclazide. Methylhydroxygliclazide belongs to the family of Benzenesulfonamides. These are organic compounds containing a sulfonamide group that is S-linked to a benzene ring.

   

N(G)-Nitroarginine-4-nitroanilide

2-amino-5-{[amino(nitroamino)methylidene]amino}-N-(4-nitrophenyl)pentanamide

C12H17N7O5 (339.1291)


   

n2-(1-Carboxyethyl)-2'-deoxyguanosine

2-({6-hydroxy-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3,9-dihydro-2H-purin-2-ylidene}amino)propanoate

C13H17N5O6 (339.1179)


   

Loxoribine

2-amino-9-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-(prop-2-en-1-yl)-6,7,8,9-tetrahydro-1H-purine-6,8-dione

C13H17N5O6 (339.1179)


   

Moguisteine

Ethyl 3-{2-[(2-methoxyphenoxy)methyl]-1,3-thiazolidin-3-yl}-3-oxopropanoic acid

C16H21NO5S (339.114)


   

Panipenem

3-[(1-ethanimidoylpyrrolidin-3-yl)sulfanyl]-6-(1-hydroxyethyl)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

C15H21N3O4S (339.1253)


   

Tox21_302226

BENZENEACETIC ACID, ALPHA-(HYDROXYMETHYL)-, 9-METHYL-3-OXA-9-AZATRICYCLO(3.3.1.0(SUP 2,4))NON-7-YL ESTER, HYDROCHLORIDE, (7(S)-(1-.ALPHA.,2-.BETA.,4-.BETA.,5-.ALPHA.,7-.BETA.))-

C17H21NO4.HCl (339.1237)


   
   
   

3-(2-hydroxyethyl)-1H-indole-5-O-beta-D-glucopyranoside

3-(2-hydroxyethyl)-1H-indole-5-O-beta-D-glucopyranoside

C16H21NO7 (339.1318)


   
   

Maybridge4_004251

Maybridge4_004251

C18H17N3O4 (339.1219)


   

MCULE-2604512160

MCULE-2604512160

C18H17N3O4 (339.1219)


   

[[1-amino-3-(5-methyl-2-oxo-1,3-benzoxazol-3-yl)propylidene]amino] benzoate

[[1-amino-3-(5-methyl-2-oxo-1,3-benzoxazol-3-yl)propylidene]amino] benzoate

C18H17N3O4 (339.1219)


   
   

SCHEMBL7911722

SCHEMBL7911722

C16H21NO5S (339.114)


   
   

desulfo-5-methylsulfanylpentyl GL|desulfoglucoberteroin|DS-GBE

desulfo-5-methylsulfanylpentyl GL|desulfoglucoberteroin|DS-GBE

C13H25NO5S2 (339.1174)


   

makomotindoline

makomotindoline

C16H21NO7 (339.1318)


   

(4S,5S,11S)-5-O-(beta-D-Xylopyranosyl)streptazolin

(4S,5S,11S)-5-O-(beta-D-Xylopyranosyl)streptazolin

C16H21NO7 (339.1318)


   
   
   
   

Tox21_302226

BENZENEACETIC ACID, ALPHA-(HYDROXYMETHYL)-, 9-METHYL-3-OXA-9-AZATRICYCLO(3.3.1.0(SUP 2,4))NON-7-YL ESTER, HYDROCHLORIDE, (7(S)-(1-.ALPHA.,2-.BETA.,4-.BETA.,5-.ALPHA.,7-.BETA.))-

C17H22ClNO4 (339.1237)


   
   

N2-S-Carboxyethyl-deoxyguanosine

N2-S-Carboxyethyl-deoxyguanosine

C13H17N5O6 (339.1179)


   
   
   
   
   
   
   

N-[[(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]carbonyl]-4-(hydroxymethyl)-Benzenesulfonamide

N-[[(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]carbonyl]-4-(hydroxymethyl)-Benzenesulfonamide

C15H21N3O4S (339.1253)


   

N-((4-hydroxyhexahydrocyclopenta[c]pyrrol-2(1H)-yl)carbamoyl)-4-methylbenzenesulfonamide

N-((4-hydroxyhexahydrocyclopenta[c]pyrrol-2(1H)-yl)carbamoyl)-4-methylbenzenesulfonamide

C15H21N3O4S (339.1253)


   

N-((5-hydroxyhexahydrocyclopenta[c]pyrrol-2(1H)-yl)carbamoyl)-4-methylbenzenesulfonamide

N-((5-hydroxyhexahydrocyclopenta[c]pyrrol-2(1H)-yl)carbamoyl)-4-methylbenzenesulfonamide

C15H21N3O4S (339.1253)


   

N-oxide gliclazide

N-oxide gliclazide

C15H21N3O4S (339.1253)


   

N-BOC-4-(P-CHLOROPHENYL)-4-PIPERIDINE CARBOXYLIC ACID

N-BOC-4-(P-CHLOROPHENYL)-4-PIPERIDINE CARBOXYLIC ACID

C17H22ClNO4 (339.1237)


   

BOC--(2-CHLORBENZYL)-DL-PRO-OH

BOC--(2-CHLORBENZYL)-DL-PRO-OH

C17H22ClNO4 (339.1237)


   

BOC--(3-CHLORBENZYL)-DL-PRO-OH

BOC--(3-CHLORBENZYL)-DL-PRO-OH

C17H22ClNO4 (339.1237)


   

cocaine Hcl

Cocaine hydrochloride

C17H22ClNO4 (339.1237)


D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018765 - Dopamine Uptake Inhibitors D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D049990 - Membrane Transport Modulators

   

Panipenem

Panipenem

C15H21N3O4S (339.1253)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D013845 - Thienamycins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

(2S,4R)-1-(tert-Butoxycarbonyl)-4-(2-chlorobenzyl)pyrrolidine-2-carboxylic acid

(2S,4R)-1-(tert-Butoxycarbonyl)-4-(2-chlorobenzyl)pyrrolidine-2-carboxylic acid

C17H22ClNO4 (339.1237)


   

Cyprazepam

7-chloro-N-(cyclopropylmethyl)-4-hydroxy-5-phenyl-3H-1,4-benzodiazepin-2-imine

C19H18ClN3O (339.1138)


C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

   

3-[(2-hydroxyethyl)[4-[(4-nitrophenyl)azo]phenyl]amino]propiononitrile

3-[(2-hydroxyethyl)[4-[(4-nitrophenyl)azo]phenyl]amino]propiononitrile

C17H17N5O3 (339.1331)


   

Loxoribine

Loxoribine

C13H17N5O6 (339.1179)


C308 - Immunotherapeutic Agent > C210 - Immunoadjuvant > C2554 - Vaccine Adjuvant C2140 - Adjuvant Loxoribine (7-Allyl-8-oxoguanosine) is a guanosine analog with anti-viral and anti-tumor activities. Loxoribine is an orally bioavailable and selective Toll-like receptor (TLR) 7 agonist[1][2][3].

   

1H-Benz[de]isoquinoline-1,3(2H)-dione,5-nitro-2-[2-(1-pyrrolidinyl)ethyl]-

1H-Benz[de]isoquinoline-1,3(2H)-dione,5-nitro-2-[2-(1-pyrrolidinyl)ethyl]-

C18H17N3O4 (339.1219)


   

n2-(1-Carboxyethyl)-2-deoxyguanosine

n2-(1-Carboxyethyl)-2-deoxyguanosine

C13H17N5O6 (339.1179)


   

Benzoic acid [[1-(4-nitrophenyl)-4-piperidinylidene]amino] ester

Benzoic acid [[1-(4-nitrophenyl)-4-piperidinylidene]amino] ester

C18H17N3O4 (339.1219)


   

8-[(1-ethyl-3-piperidinyl)thio]-1,3-dimethyl-6-sulfanylidene-7H-purin-2-one

8-[(1-ethyl-3-piperidinyl)thio]-1,3-dimethyl-6-sulfanylidene-7H-purin-2-one

C14H21N5OS2 (339.1187)


   

N(2)-(S)-carboxyethyl-2-deoxyguanosine

N(2)-(S)-carboxyethyl-2-deoxyguanosine

C13H17N5O6 (339.1179)


   

N(2)-(R)-carboxyethyl-2-deoxyguanosine

N(2)-(R)-carboxyethyl-2-deoxyguanosine

C13H17N5O6 (339.1179)


   

3-(Hydroxy-phenyl-phosphinoyloxy)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylic acid methyl ester

3-(Hydroxy-phenyl-phosphinoyloxy)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylic acid methyl ester

C16H22NO5P (339.1236)


   

(2r,3r,4r,5r)-4,5-Dihydroxy-2-(Hydroxymethyl)-6-Oxopiperidin-3-Yl Beta-D-Glucopyranoside

(2r,3r,4r,5r)-4,5-Dihydroxy-2-(Hydroxymethyl)-6-Oxopiperidin-3-Yl Beta-D-Glucopyranoside

C12H21NO10 (339.1165)


   

N(G)-Nitroarginine-4-nitroanilide

2-amino-5-{[amino(nitroamino)methylidene]amino}-N-(4-nitrophenyl)pentanamide

C12H17N7O5 (339.1291)


   

Panipenem

3-[(1-ethanimidoylpyrrolidin-3-yl)sulfanyl]-6-(1-hydroxyethyl)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

C15H21N3O4S (339.1253)


   

3,5-dihydroxy-2-[(2E)-3-(4-hydroxyphenyl)prop-2-enoyl]-6-(3-methylbut-2-en-1-yl)phenolate

3,5-dihydroxy-2-[(2E)-3-(4-hydroxyphenyl)prop-2-enoyl]-6-(3-methylbut-2-en-1-yl)phenolate

C20H19O5- (339.1232)


   

7-Hydroxy-2-(4-hydroxyphenyl)-6-(3-methylbut-2-enyl)-4-oxo-2,3-dihydrochromen-5-olate

7-Hydroxy-2-(4-hydroxyphenyl)-6-(3-methylbut-2-enyl)-4-oxo-2,3-dihydrochromen-5-olate

C20H19O5- (339.1232)


   

2-[1-[(4-Amino-2-methylpyrimidin-5-yl)methyl]-2-methylpyridin-1-ium-3-yl]ethyl dihydrogen phosphate

2-[1-[(4-Amino-2-methylpyrimidin-5-yl)methyl]-2-methylpyridin-1-ium-3-yl]ethyl dihydrogen phosphate

C14H20N4O4P+ (339.1222)


   

2-amino-9-[3,4-dihydroxy-5-(hydroxymethyl)-2-oxolanyl]-7-prop-2-enyl-3H-purine-6,8-dione

2-amino-9-[3,4-dihydroxy-5-(hydroxymethyl)-2-oxolanyl]-7-prop-2-enyl-3H-purine-6,8-dione

C13H17N5O6 (339.1179)


   

2-[[9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-oxo-1H-purin-2-yl]amino]propanoic acid

2-[[9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-oxo-1H-purin-2-yl]amino]propanoic acid

C13H17N5O6 (339.1179)


   

N-(4-chlorophenyl)-5-methyl-2-[(4-methylphenyl)methyl]-3-pyrazolecarboxamide

N-(4-chlorophenyl)-5-methyl-2-[(4-methylphenyl)methyl]-3-pyrazolecarboxamide

C19H18ClN3O (339.1138)


   

sophoraflavanone B(1-)

sophoraflavanone B(1-)

C20H19O5- (339.1232)


Conjugate base of sophoraflavanone B arising from deprotonation of the 7-hydroxy group.

   

2-[[4-(2,4-Dimethylphenyl)-5-(3-pyridinyl)-1,2,4-triazol-3-yl]thio]acetamide

2-[[4-(2,4-Dimethylphenyl)-5-(3-pyridinyl)-1,2,4-triazol-3-yl]thio]acetamide

C17H17N5OS (339.1154)


   

4-[4-(3-Methoxyphenyl)-6-(trifluoromethyl)-2-pyrimidinyl]morpholine

4-[4-(3-Methoxyphenyl)-6-(trifluoromethyl)-2-pyrimidinyl]morpholine

C16H16F3N3O2 (339.1195)


   

N-(5-methyl-7-phenyl-1,5,6,7-tetrahydro-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-2-thiophenecarboxamide

N-(5-methyl-7-phenyl-1,5,6,7-tetrahydro-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-2-thiophenecarboxamide

C17H17N5OS (339.1154)


   

1-(3-Chloro-4-fluorophenyl)-4-[(4-methyl-1-piperazinyl)-oxomethyl]-2-pyrrolidinone

1-(3-Chloro-4-fluorophenyl)-4-[(4-methyl-1-piperazinyl)-oxomethyl]-2-pyrrolidinone

C16H19ClFN3O2 (339.115)


   

(1R,2R,3S,5S)-3-(benzoyloxy)-2-(methoxycarbonyl)-8-methyl-8-azoniabicyclo[3.2.1]octane chloride

(1R,2R,3S,5S)-3-(benzoyloxy)-2-(methoxycarbonyl)-8-methyl-8-azoniabicyclo[3.2.1]octane chloride

C17H22ClNO4 (339.1237)


   

N-(3,4-dimethylphenyl)-2-[(5-pyridin-4-yl-1H-1,2,4-triazol-3-yl)thio]acetamide

N-(3,4-dimethylphenyl)-2-[(5-pyridin-4-yl-1H-1,2,4-triazol-3-yl)thio]acetamide

C17H17N5OS (339.1154)


   

2-[1-[(2-chloro-6-fluorophenyl)methyl]-3-oxo-2-piperazinyl]-N-prop-2-enylacetamide

2-[1-[(2-chloro-6-fluorophenyl)methyl]-3-oxo-2-piperazinyl]-N-prop-2-enylacetamide

C16H19ClFN3O2 (339.115)


   

N-[(E)-1-(3-Acetamidophenyl)ethylideneamino]-1,3-benzodioxole-5-carboxamide

N-[(E)-1-(3-Acetamidophenyl)ethylideneamino]-1,3-benzodioxole-5-carboxamide

C18H17N3O4 (339.1219)


   
   

3-(benzotriazol-1-yl)-N-[(E)-(2-hydroxy-5-methoxyphenyl)methylideneamino]propanamide

3-(benzotriazol-1-yl)-N-[(E)-(2-hydroxy-5-methoxyphenyl)methylideneamino]propanamide

C17H17N5O3 (339.1331)


   
   
   
   
   
   

1-[(1S,2S)-2-[(3-chlorophenyl)methoxy]-1,2,3,4-tetrahydronaphthalen-1-yl]triazole

1-[(1S,2S)-2-[(3-chlorophenyl)methoxy]-1,2,3,4-tetrahydronaphthalen-1-yl]triazole

C19H18ClN3O (339.1138)


   

desmethylxanthohumol(1-)

desmethylxanthohumol(1-)

C20H19O5 (339.1232)


A phenolate anion that is the conjugate base of xanthohumol, obtained by deprotonation of the 1-hydroxy group. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).

   

5-Hydroxytryptophol glucuronide

5-Hydroxytryptophol glucuronide

C16H21NO7 (339.1318)


   

Methylhydroxygliclazide

Methylhydroxygliclazide

C15H21N3O4S (339.1253)


   

7-Hydroxygliclazide

7-Hydroxygliclazide

C15H21N3O4S (339.1253)


   

O-hydroxy(phenyl)phosphinoyl ecgonine methyl ester

O-hydroxy(phenyl)phosphinoyl ecgonine methyl ester

C16H22NO5P (339.1236)


The O-hydroxy(phenyl)phosphinoyl derivative of ecgonine methyl ester.

   

Hydroxytryptophol glucuronide

Hydroxytryptophol glucuronide

C16H21NO7 (339.1318)


   

VU6010572

VU6010572

C20H18FNO3 (339.1271)


VU6010572 is a potent and selective mGlu3 negative allosteric modulator with IC50 of 245 nM. VU6010572 is highly CNS penetrant[1][2].

   

methyl 7-[3-amino-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-2-imino-1h-pyrrolo[2,3-d]pyrimidine-5-carboxylate

methyl 7-[3-amino-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-2-imino-1h-pyrrolo[2,3-d]pyrimidine-5-carboxylate

C13H17N5O6 (339.1179)


   

methyl 3-{[1-(1-hydroxyethyl)-9h-pyrido[3,4-b]indol-3-yl]formamido}prop-2-enoate

methyl 3-{[1-(1-hydroxyethyl)-9h-pyrido[3,4-b]indol-3-yl]formamido}prop-2-enoate

C18H17N3O4 (339.1219)


   

(4s,5s,6z,11s)-6-ethylidene-5-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-3-oxa-1-azatricyclo[5.3.1.0⁴,¹¹]undec-7-en-2-one

(4s,5s,6z,11s)-6-ethylidene-5-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-3-oxa-1-azatricyclo[5.3.1.0⁴,¹¹]undec-7-en-2-one

C16H21NO7 (339.1318)


   

methyl (2z)-3-({1-[(1r)-1-hydroxyethyl]-9h-pyrido[3,4-b]indol-3-yl}formamido)prop-2-enoate

methyl (2z)-3-({1-[(1r)-1-hydroxyethyl]-9h-pyrido[3,4-b]indol-3-yl}formamido)prop-2-enoate

C18H17N3O4 (339.1219)


   

methyl (2z)-3-({1-[(1s)-1-hydroxyethyl]-9h-pyrido[3,4-b]indol-3-yl}formamido)prop-2-enoate

methyl (2z)-3-({1-[(1s)-1-hydroxyethyl]-9h-pyrido[3,4-b]indol-3-yl}formamido)prop-2-enoate

C18H17N3O4 (339.1219)


   

methyl 3-({1-acetyl-9h-pyrido[3,4-b]indol-3-yl}formamido)propanoate

methyl 3-({1-acetyl-9h-pyrido[3,4-b]indol-3-yl}formamido)propanoate

C18H17N3O4 (339.1219)